Award recordCONTRACT

WILSHIRE PHARMACEUTICALS, INC

PIID V797D30156· VA Staff Offices· NAC FEDERAL SUPPLY SCHEDULE (36F797)· 6505 · DRUGS AND BIOLOGICALS· FY2014· $0 net obligations· UEI P6JJN5UNWJD5· GA

Description

CONTRACT CANCELLATION - FOLLOW-ON OFFER AWARD

Base award description: 651B PHARMACEUTICALS

First action · last action
2014-03-04 · 2019-12-10
Transactions
14
First transaction's obligation
$0
Base + all options value (sum of deltas)
$19,687,770
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
999
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 14 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2014-03-04 · this action $0 · running total $0Modification P00001 · 2014-05-07 · this action $0 · running total $0Modification P00002 · 2014-12-20 · this action $0 · running total $0Modification P00004 · 2015-12-22 · this action $0 · running total $0Modification P00005 · 2016-02-29 · this action $0 · running total $0Modification P00006 · 2016-07-19 · this action $0 · running total $0Modification P00007 · 2016-11-01 · this action $0 · running total $0Modification P00008 · 2017-07-13 · this action $0 · running total $0Modification P00009 · 2018-03-30 · this action $0 · running total $0Modification P00010 · 2018-04-04 · this action $0 · running total $0Modification P00011 · 2019-01-22 · this action $0 · running total $0Modification P00012 · 2019-02-21 · this action $0 · running total $0Modification P00013 · 2019-09-05 · this action $0 · running total $0Modification P00014 · 2019-12-10 · this action $0 · running total $0
  • Base2014-03-04+$0= $0
  • Mod P000012014-05-07+$0= $0
  • Mod P000022014-12-20+$0= $0
  • Mod P000042015-12-22+$0= $0
  • Mod P000052016-02-29+$0= $0
  • Mod P000062016-07-19+$0= $0
  • Mod P000072016-11-01+$0= $0
  • Mod P000082017-07-13+$0= $0
  • Mod P000092018-03-30+$0= $0
  • Mod P000102018-04-04+$0= $0
  • Mod P000112019-01-22+$0= $0
  • Mod P000122019-02-21+$0= $0
  • Mod P000132019-09-05+$0= $0
  • Mod P000142019-12-10+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2014-03-04+$0$0651B PHARMACEUTICALS
Mod P00001· OTHER ADMINISTRATIVE ACTION2014-05-07+$0$0651B PHARMACEUTICALS
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2014-12-20+$0$0651B DRUGS, PHARMACEUTICALS AND HEMATOLOGY PRODUCTS / PUBLIC LAW 2015.
Mod P00004· ENTITY ADDRESS CHANGE2015-12-22+$0$065IB - DRUGS, PHARMACEUTICALS AND HEMATOLOGY PRODUCTS / 2016 PUBLIC LAW UPDATES.
Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2016-02-29+$0$065IB - DRUGS, PHARMACEUTICALS AND HEMATOLOGY PRODUCTS / SIGNATORY AUTHORITY FORM CHANGE.
Mod P00006· OTHER ADMINISTRATIVE ACTION2016-07-19+$0$0ADMIN. POC CHANGE: KEVIN JOHNSON; JENNIFER CROSSWELL
Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2016-11-01+$0$0DELETION OF TWO (2) NITROGLYCERIN LINGUAL PRODUCTS.
Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2017-07-13+$0$042-2B PRODUCT DELETION (4) NDCS
Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2018-03-30+$0$0PRODUCT ADDITION
Mod P00010· ENTITY ADDRESS CHANGE2018-04-04+$0$0ADMINISTRATIVE CHANGE
Mod P00011· OTHER ADMINISTRATIVE ACTION2019-01-22+$0$0PRODUCT DELETION
Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2019-02-21+$0$0TEMPORARY CONTRACT EXTENSION
Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2019-09-05+$0$0TEMPORARY CONTRACT EXTENSION
Mod P00014· LEGAL CONTRACT CANCELLATION2019-12-10+$0$0CONTRACT CANCELLATION - FOLLOW-ON OFFER AWARD

Related awards · 7

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI P6JJN5UNWJD5)

AwardOffice · PSC / listingNet obligationsFY
36F79726D0208NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36F79720D0043NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2020

Other recipients under 6505 from NAC FEDERAL SUPPLY SCHEDULE (36F797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36F79726D021260 DEGREES PHARMACEUTICALS, INC.NAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D066ETRAVERE THERAPEUTICS, INC.NAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0210GENZYME CORPORATIONNAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0202CYTOKINETICS, INCORPORATEDNAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0204LANTHEUS MEDICAL IMAGING, INC.NAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_V797D30156_3600 · retrieved 2026-09-27.